OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dose‐escalation study evaluating pegylated interferon alpha‐2a in patients with cutaneous T‐cell lymphoma
M. Schiller, Athanasios Tsianakas, Wolfram Sterry, et al.
Journal of the European Academy of Dermatology and Venereology (2017) Vol. 31, Iss. 11, pp. 1841-1847
Closed Access | Times Cited: 22
M. Schiller, Athanasios Tsianakas, Wolfram Sterry, et al.
Journal of the European Academy of Dermatology and Venereology (2017) Vol. 31, Iss. 11, pp. 1841-1847
Closed Access | Times Cited: 22
Showing 22 citing articles:
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023
Johanna Latzka, Chalid Assaf, M. Bagot, et al.
European Journal of Cancer (2023) Vol. 195, pp. 113343-113343
Open Access | Times Cited: 67
Johanna Latzka, Chalid Assaf, M. Bagot, et al.
European Journal of Cancer (2023) Vol. 195, pp. 113343-113343
Open Access | Times Cited: 67
S2k‐Guidelines – Cutaneous lymphomas (ICD10 C82 ‐ C86): Update 2021
Edgar Dippel, Chalid Assaf, Jürgen C. Becker, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2022) Vol. 20, Iss. 4, pp. 537-554
Open Access | Times Cited: 39
Edgar Dippel, Chalid Assaf, Jürgen C. Becker, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2022) Vol. 20, Iss. 4, pp. 537-554
Open Access | Times Cited: 39
Real-world study of pegylated interferon α-2a to treat mycosis fungoides/Sézary syndrome using time to next treatment as a measure of clinical benefit: an EORTC CLTG study
Keila Mitsunaga, M. Bagot, C. Ram‐Wolff, et al.
British Journal of Dermatology (2024) Vol. 191, Iss. 3, pp. 419-427
Closed Access | Times Cited: 7
Keila Mitsunaga, M. Bagot, C. Ram‐Wolff, et al.
British Journal of Dermatology (2024) Vol. 191, Iss. 3, pp. 419-427
Closed Access | Times Cited: 7
Mycosis Fungoides and Sézary Syndrome: An Integrative Review of the Pathophysiology, Molecular Drivers, and Targeted Therapy
Nuria García‐Díaz, Miguel Á. Piris, Pablo L. Ortiz‐Romero, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1931-1931
Open Access | Times Cited: 37
Nuria García‐Díaz, Miguel Á. Piris, Pablo L. Ortiz‐Romero, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1931-1931
Open Access | Times Cited: 37
S2k‐Leitlinie – Kutane Lymphome (ICD10 C82–C86): Update 2021
Edgar Dippel, Chalid Assaf, Jürgen C. Becker, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2022) Vol. 20, Iss. 4, pp. 537-555
Open Access | Times Cited: 22
Edgar Dippel, Chalid Assaf, Jürgen C. Becker, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2022) Vol. 20, Iss. 4, pp. 537-555
Open Access | Times Cited: 22
PLGA Polymers and Doxorubicin for the Treatment of Malignant Gliomas in Adults: An Overview
V. V. Kudelkina, Andrey D. Gerasimov, А. М. Косырева, et al.
The Open Medicinal Chemistry Journal (2025) Vol. 19, Iss. 1
Open Access
V. V. Kudelkina, Andrey D. Gerasimov, А. М. Косырева, et al.
The Open Medicinal Chemistry Journal (2025) Vol. 19, Iss. 1
Open Access
Use of Pegylated Interferon Alpha-2a in Cutaneous T-cell Lymphoma: A Retrospective Case Collection
Janika Gosmann, Rudolf Stadler, Koen D. Quint, et al.
Acta Dermato Venereologica (2023) Vol. 103, pp. adv10306-adv10306
Open Access | Times Cited: 8
Janika Gosmann, Rudolf Stadler, Koen D. Quint, et al.
Acta Dermato Venereologica (2023) Vol. 103, pp. adv10306-adv10306
Open Access | Times Cited: 8
Pegylated interferon‐α2a in cutaneous T‐cell lymphoma – a multicenter retrospective data analysis with 70 patients
Inga Hansen, Glenn Geidel, Finn Abeck, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024) Vol. 22, Iss. 11, pp. 1489-1497
Open Access | Times Cited: 2
Inga Hansen, Glenn Geidel, Finn Abeck, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024) Vol. 22, Iss. 11, pp. 1489-1497
Open Access | Times Cited: 2
Mycosis fungoides and Sézary syndrome: focus on the current treatment scenario
José Antônio Sanches, Jade Cury‐Martins, Rodrigo Martins Abreu, et al.
Anais Brasileiros de Dermatologia (2021) Vol. 96, Iss. 4, pp. 458-471
Open Access | Times Cited: 14
José Antônio Sanches, Jade Cury‐Martins, Rodrigo Martins Abreu, et al.
Anais Brasileiros de Dermatologia (2021) Vol. 96, Iss. 4, pp. 458-471
Open Access | Times Cited: 14
The use of pegylated interferon a‐2a in a cohort of Greek patients with mycosis fungoides
Aikaterini Patsatsi, Evangelia Papadavid, Aikaterini Kyriakou, et al.
Journal of the European Academy of Dermatology and Venereology (2021) Vol. 36, Iss. 4
Closed Access | Times Cited: 11
Aikaterini Patsatsi, Evangelia Papadavid, Aikaterini Kyriakou, et al.
Journal of the European Academy of Dermatology and Venereology (2021) Vol. 36, Iss. 4
Closed Access | Times Cited: 11
Integrating novel systemic therapies for the treatment of mycosis fungoides and Sézary syndrome
H. Miles Prince, Christiane Querfeld
Best Practice & Research Clinical Haematology (2018) Vol. 31, Iss. 3, pp. 322-335
Closed Access | Times Cited: 9
H. Miles Prince, Christiane Querfeld
Best Practice & Research Clinical Haematology (2018) Vol. 31, Iss. 3, pp. 322-335
Closed Access | Times Cited: 9
Non-pegylated and Pegylated Interferon Alpha-2a in Cutaneous T-cell Lymphoma and the Risk of Severe Ocular Side-effects
Jana D. Albrecht, Nadia Ninosu, Denise Barry, et al.
Acta Dermato Venereologica (2022) Vol. 102, pp. adv00722-adv00722
Open Access | Times Cited: 5
Jana D. Albrecht, Nadia Ninosu, Denise Barry, et al.
Acta Dermato Venereologica (2022) Vol. 102, pp. adv00722-adv00722
Open Access | Times Cited: 5
Cost-Effectiveness of Extracorporeal Photopheresis for the Treatment of Patients With Erythrodermic (Stage T4, M0) Cutaneous T-Cell Lymphoma in the Australian Setting
A. Peacock, Francis C. Dehle, O.A. Mesa Zapata, et al.
Value in Health (2022) Vol. 25, Iss. 6, pp. 965-974
Open Access | Times Cited: 3
A. Peacock, Francis C. Dehle, O.A. Mesa Zapata, et al.
Value in Health (2022) Vol. 25, Iss. 6, pp. 965-974
Open Access | Times Cited: 3
Skin-directed therapy and biologic response modifiers in mycosis fungoides
Vieri Grandi, Virginia Alba Colantuono, Nicola Pimpinelli
Dermatology Reports (2024) Vol. 16, Iss. s2
Open Access
Vieri Grandi, Virginia Alba Colantuono, Nicola Pimpinelli
Dermatology Reports (2024) Vol. 16, Iss. s2
Open Access
Pegyliertes Interferon‐α2a bei kutanen T‐Zell‐Lymphomen – eine multizentrische retrospektive Datenanalyse mit 70 Patienten
Inga Hansen, Glenn Geidel, Finn Abeck, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024) Vol. 22, Iss. 11, pp. 1489-1498
Open Access
Inga Hansen, Glenn Geidel, Finn Abeck, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024) Vol. 22, Iss. 11, pp. 1489-1498
Open Access
Mycosis fungoides and Sezary syndrome – Simplifying the approach for dermatologists. Part 2: Evaluation, staging, prognosis and treatment
Gautam Kumar Singh, Pankaj Das, Sarita Srivastava, et al.
Indian Journal of Dermatology Venereology and Leprology (2024), pp. 1-8
Open Access
Gautam Kumar Singh, Pankaj Das, Sarita Srivastava, et al.
Indian Journal of Dermatology Venereology and Leprology (2024), pp. 1-8
Open Access
Transitioning to Pegylated Interferon for the Treatment of Cutaneous T-Cell Lymphoma: Meeting the Challenge of Therapy Discontinuation and a Proposed Algorithm
Selena Osman, Justin Chia, Lesley Street, et al.
Dermatologic Therapy (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 1
Selena Osman, Justin Chia, Lesley Street, et al.
Dermatologic Therapy (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 1
Early intervention of extracorporeal photopheresis for advancing/progressing cutaneous T‐cell lymphoma
Daniel Aires, Sunil Abhyankar
Hematological Oncology (2023) Vol. 41, Iss. 5, pp. 809-816
Closed Access | Times Cited: 1
Daniel Aires, Sunil Abhyankar
Hematological Oncology (2023) Vol. 41, Iss. 5, pp. 809-816
Closed Access | Times Cited: 1
Primary cutaneous follicle centre lymphoma, spindle cell type, presenting with multicentre figurated erythema and complete remission after intralesional injections of ultra‐low‐dose Interferon alpha‐2a
Lyubomira Vlahova, Werner Kempf, Michael P. Schön, et al.
Journal of the European Academy of Dermatology and Venereology (2020) Vol. 35, Iss. 3
Closed Access | Times Cited: 1
Lyubomira Vlahova, Werner Kempf, Michael P. Schön, et al.
Journal of the European Academy of Dermatology and Venereology (2020) Vol. 35, Iss. 3
Closed Access | Times Cited: 1
Cytokine Therapy in Dermatology
Sushruta Kathuria, Torello Lotti
Springer eBooks (2023), pp. 1637-1644
Closed Access
Sushruta Kathuria, Torello Lotti
Springer eBooks (2023), pp. 1637-1644
Closed Access
Aktuelle Therapieoptionen bei Mycosis fungoides und Sézary-Syndrom
Jana D. Albrecht, Jan P. Nicolay
Der Hautarzt (2022) Vol. 73, Iss. 1, pp. 75-85
Closed Access
Jana D. Albrecht, Jan P. Nicolay
Der Hautarzt (2022) Vol. 73, Iss. 1, pp. 75-85
Closed Access
Micose fungoide e síndrome de Sézary: foco no cenário atual de tratamento
José Antônio Sanches, Jade Cury‐Martins, Rodrigo Martins Abreu, et al.
(2021) Vol. 96, Iss. 4, pp. 458-471
Open Access
José Antônio Sanches, Jade Cury‐Martins, Rodrigo Martins Abreu, et al.
(2021) Vol. 96, Iss. 4, pp. 458-471
Open Access
